Let it Flow: Automated Low Volume Viscosity Measurements with Junior

Biologic drug products typically need to be manufacturable and deliverable at high concentrations. High concentration monoclonal antibody (mAb) formulations are often highly viscous, making the manufacture and delivery of these formulations potentially problematic. Measuring the viscosity of a biologic formulation at its intended final concentration can help to more fully characterize the developability of the biologic
drug product.